Faculty Opinions recommendation of Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Plasma Dna ◽

Pik3ca Mutations ◽

Free Plasma ◽

Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing

Clinical Breast Cancer ◽

10.1016/j.clbc.2016.05.004 ◽

2016 ◽

Vol 16 (5) ◽

pp. 418-423 ◽

Cited By ~ 20

Author(s):

Chiaki Nakauchi ◽

Naofumi Kagara ◽

Kenzo Shimazu ◽

Atsushi Shimomura ◽

Yasuto Naoi ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Plasma Dna ◽

Pik3ca Mutations ◽

Free Plasma ◽

miRNA profile obtained by next‑generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments

International Journal of Molecular Medicine ◽

10.3892/ijmm.2019.4292 ◽

2019 ◽

Cited By ~ 3

Author(s):

Antonio Martinez‑Gutierrez ◽

Oliver Catalan ◽

Rafael V�zquez‑Romo ◽

Fany Porras Reyes ◽

Alberto Alvarado‑Miranda ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Mirna Profile ◽

Next Generation ◽

Breast Cancer Patients ◽

Systemic Treatments ◽

Real world data analysis of next generation sequencing and protein expression in metastatic breast cancer patients

Scientific Reports ◽

10.1038/s41598-020-67393-9 ◽

2020 ◽

Vol 10 (1) ◽

Cited By ~ 2

Author(s):

Dirk Hempel ◽

Florian Ebner ◽

Arun Garg ◽

Zeljka Trepotec ◽

Armin Both ◽

...

Keyword(s):

Breast Cancer ◽

Data Analysis ◽

Cancer Patients ◽

Real World ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Real World Data ◽

Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing

Breast Cancer Research and Treatment ◽

10.1007/s10549-017-4190-z ◽

2017 ◽

Vol 163 (2) ◽

pp. 231-240 ◽

Cited By ~ 18

Author(s):

Takehiro Yanagawa ◽

Naofumi Kagara ◽

Tomohiro Miyake ◽

Tomonori Tanei ◽

Yasuto Naoi ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Next Generation ◽

Breast Cancer Patients ◽

Esr1 Mutations ◽

S3-3: Association of PTEN Loss and PIK3CA Mutations on Outcome in HER2+ Metastatic Breast Cancer Patients Treated with First-Line Lapatinib Plus Paclitaxel or Paclitaxel Alone.

10.1158/0008-5472.sabcs11-s3-3 ◽

2011 ◽

Cited By ~ 1

Author(s):

B Xu ◽

Z-Z Guan ◽

Z-Z Shen ◽

Z-S Tong ◽

Z-F Jiang ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Pik3ca Mutations ◽

Pten Loss

Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients

British Journal of Cancer ◽

10.1038/s41416-021-01601-9 ◽

2021 ◽

Author(s):

Christoph Suppan ◽

Ricarda Graf ◽

Stephan Jahn ◽

Qing Zhou ◽

Eva Valentina Klocker ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Hormone Receptor ◽

Liquid Biopsy ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Pik3ca Mutations ◽

Hormone Receptor Positive

PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy

Breast Cancer Research and Treatment ◽

10.1007/s10549-019-05349-y ◽

2019 ◽

Vol 177 (3) ◽

pp. 659-667 ◽

Cited By ~ 6

Author(s):

William Jacot ◽

Florence Dalenc ◽

Evelyne Lopez-Crapez ◽

Leonor Chaltiel ◽

Anna Durigova ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factor ◽

Cancer Patients ◽

Hormonal Therapy ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Pik3ca Mutations ◽

Negative Prognostic Factor ◽

Tumor Dna

57P Benefit of CDK4/6 inhibitors beyond PIK3CA mutations in metastatic breast cancer patients

Annals of Oncology ◽

10.1016/j.annonc.2020.03.191 ◽

2020 ◽

Vol 31 ◽

pp. S35

Author(s):

P. Tolosa Ortega ◽

J.M. Cejalvo ◽

S. Moragon Terencio ◽

L. Carril-Ajuria ◽

B. Bermejo ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Pik3ca Mutations

Impact OF PIK3CA Mutations and P95HER2 Expression on the Outcome of HER2-Positive Metastatic Breast Cancer Patients Treated With a Trastuzumab-Based Therapy

Annals of Oncology ◽

10.1016/s0923-7534(20)32811-8 ◽

2012 ◽

Vol 23 ◽

pp. ix94

Author(s):

I. Stasi ◽

A. Fontana ◽

G. Allegrini ◽

C. Mazzanti ◽

S. Lucchesi ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Pik3ca Mutations

P4-07-05: Comparison of PIK3CA Hot Spot Mutations in the Primary Tumor or Metastases with PIK3CA Mutations or PIK3CA Over-Expression in Circulating Tumor Cells of Metastatic Breast Cancer Patients under Sequential Palliative Therapy.

10.1158/0008-5472.sabcs11-p4-07-05 ◽

2011 ◽

Author(s):

B Aktas ◽

S Kasimir-Bauer ◽

S Kasper ◽

C Derks ◽

R Kimmig ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Hot Spot ◽

Palliative Therapy ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Pik3ca Mutations ◽

Over Expression